Carcidiag Biotechnologies
Develops a technology to better and identify early tumor.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD10—15m (Dealroom.co estimates Jun 2018.)
Company register number 824972822
Guéret Nouvelle-Aquitaine (HQ)
Financials
Estimates*
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m |
| % growth | - | (99 %) | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€1.5m | Seed | ||
| Total Funding | AUD2.6m | ||
Related Content
Recent News about Carcidiag Biotechnologies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.